Global Artificial Tear For Dry Eye Treatment Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Artificial Tear For Dry Eye Treatment Market Insights, Forecast to 2034
Artificial tears for dry eye treatment are specially formulated eye drops that help alleviate the symptoms of dry eye syndrome. Dry eye syndrome occurs when the eyes do not produce enough tears or when the tears evaporate too quickly, leading to dryness, irritation, and discomfort. Artificial tears work by lubricating and moisturizing the surface of the eyes, providing relief from symptoms such as dryness, burning, itching, redness, and blurred vision. They help to maintain proper eye moisture and promote tear film stability.
Global Artificial Tear For Dry Eye Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Artificial Tear For Dry Eye Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global dry eye treatment market had been experiencing steady growth due to factors such as an aging population, increased screen time, and awareness about eye health. North America, particularly the United States and Canada, held the largest share in the global dry eye treatment market. This was attributed to a high prevalence of dry eye syndrome, a well-established healthcare infrastructure, and a growing aging population. Regulatory bodies such as the FDA played a crucial role in product approvals and market growth. The European market for dry eye treatment was also significant, driven by factors like an aging population and increasing awareness about eye health. Key countries in this region included Germany, France, and the United Kingdom. The European Medicines Agency (EMA) regulated products in this market. The Asia-Pacific region, led by countries like Japan, China, and South Korea, exhibited rapid growth in the dry eye treatment market. Factors contributing to this growth included a rising middle-class population, increased screen time, and changing lifestyles. Regulatory agencies in these countries had varying approval processes.
Report Covers
This report presents an overview of global Artificial Tear For Dry Eye Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Artificial Tear For Dry Eye Treatment market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Alcon
Allergan (AbbVie)
Bausch & Lomb
Johnson & Johnson
Ursapharm
Santen Pharmaceutical
Rohto
Similasan
Ocusoft
HYLO
Novax Pharma
Wuhan Yuanda
Segment by Type
Dose1ml
Dose5ml
Dose10ml
Others
Hospital
Drug Store
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Artificial Tear For Dry Eye Treatment plant distribution, commercial date of Artificial Tear For Dry Eye Treatment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Artificial Tear For Dry Eye Treatment introduction, etc. Artificial Tear For Dry Eye Treatment Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Artificial Tear For Dry Eye Treatment
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Artificial Tear For Dry Eye Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Artificial Tear For Dry Eye Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global dry eye treatment market had been experiencing steady growth due to factors such as an aging population, increased screen time, and awareness about eye health. North America, particularly the United States and Canada, held the largest share in the global dry eye treatment market. This was attributed to a high prevalence of dry eye syndrome, a well-established healthcare infrastructure, and a growing aging population. Regulatory bodies such as the FDA played a crucial role in product approvals and market growth. The European market for dry eye treatment was also significant, driven by factors like an aging population and increasing awareness about eye health. Key countries in this region included Germany, France, and the United Kingdom. The European Medicines Agency (EMA) regulated products in this market. The Asia-Pacific region, led by countries like Japan, China, and South Korea, exhibited rapid growth in the dry eye treatment market. Factors contributing to this growth included a rising middle-class population, increased screen time, and changing lifestyles. Regulatory agencies in these countries had varying approval processes.
Report Covers
This report presents an overview of global Artificial Tear For Dry Eye Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Artificial Tear For Dry Eye Treatment market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alcon
Allergan (AbbVie)
Bausch & Lomb
Johnson & Johnson
Ursapharm
Santen Pharmaceutical
Rohto
Similasan
Ocusoft
HYLO
Novax Pharma
Wuhan Yuanda
Segment by Type
Dose1ml
Dose5ml
Dose10ml
Others
Segment by Application
Hospital
Drug Store
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Artificial Tear For Dry Eye Treatment plant distribution, commercial date of Artificial Tear For Dry Eye Treatment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Artificial Tear For Dry Eye Treatment introduction, etc. Artificial Tear For Dry Eye Treatment Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Artificial Tear For Dry Eye Treatment
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices